Latest Updates
-
Who Is Nida Khan? Inside the TCS Nashik Controversy and What the Law Says About Pregnancy and Arrest -
Indo Chinese Street Style Veg Manchurian Recipe: A Flavorful Snack -
Fashion Hacks 101: Summer Wardrobe Mistakes That Make You Feel Hotter -
Home Remedies to Prevent Tanning This Summer Without Overdoing Skincare -
Akshaya Tritiya 2026: Rinhee Suberwal Guides What to Buy and Avoid Based on Your Zodiac Sign -
Aloo Palak Recipe: Your Iron Rich Healthy Curry -
Vaishakh Amavasya 2026: Date, Timings, Dos and Don’ts to Follow -
What To Watch This Week (April 13–19): Fresh OTT Releases Across Netflix, JioHotstar, Prime Video And More -
Quick 5 Minute Breakfast Veg Sandwich Recipe -
Horoscope for Today Apr 17, 2026 - Small Choices, Steady Progress
Rat Poison To Reduce Heart Attack Risk

According to a study published in the New England Journal of Medicine, a new drug developed as an alternative to popular drug warfarin, also used as rat poison, has been found to significantly reduce stroke risk.
Though there does exist the practice of giving warfarin to patients at risk of stroke, however, the treatment is considered to be quite dangerous and a regular supervision has to be maintained during the process.
In the new study, the doctors found that the new drug, dabigatran (Pradaxa), was 34 per cent more effective at reducing the heart risk and blood clots in at-risk patients than well-controlled warfarin. It also reduced death rates by 15 per cent.
In the three-year long study, the researchers recruited patients with an average age of 71, all of whom suffered from atrial fibrillation, a heart rhythm disorder that greatly increases the risk of stroke.
The British Heart Foundation said that the results for an alternative to warfarin were promising, but the drug would not be available to patients until next year at the earliest.
"Warfarin is a highly effective treatment when indicated for stroke prevention, but it is underused, often because of safety concerns or the need for regular blood tests to monitor its effects," Times Online quoted Keith Muir, a medical advisor for the Stroke Association, as saying.
The trial indicates that dabigatran may offer a useful alternative to warfarin for stroke prevention in some circumstances. "However, the trial only involved people who could equally well have taken warfarin, and anyone currently taking warfarin should continue it unless advised by their doctor," he added.
AGENCIES



Click it and Unblock the Notifications